News & Perspective

Jul 21, 2008

Jul 21, 2008

More efforts look outside the box for outbreak signals

(CIDRAP News) – In the history of infectious diseases, coincidence plays an extraordinary role. In 1706, Cotton Mather purchased a slave named Onesimus who happened to come from a tribe that practiced variolation, and so smallpox prevention was introduced to North America.

Jul 10, 2008

Jul 10, 2008

Marburg fever case reported in Netherlands

(CIDRAP News) – European officials today reported a rare case of the often-deadly Marburg hemorrhagic fever on European soil, in a Dutch woman who recently was exposed to bats while visiting caves in Uganda.

Jun 16, 2008

Jun 16, 2008

Sanofi to give WHO 60 million doses of H5N1 vaccine

(CIDRAP News) – Sanofi Pasteur pledged today to give 60 million doses of H5N1 influenza vaccine over 3 years to the World Health Organization (WHO) for a planned stockpile to help poor countries in the event of an influenza pandemic.

May 19, 2008

May 19, 2008

EU approves its first prepandemic H5N1 vaccine

(CIDRAP News) – An H5N1 influenza vaccine made by the British pharmaceutical company GlaxoSmithKline (GSK) has become the first prepandemic vaccine to be licensed by the European Union (EU), the company announced today.

May 06, 2008

May 06, 2008

Pew report urges limiting antimicrobial use in animals

(CIDRAP News) – After a 2-year study of the effects of large-scale farm animal production, a panel of experts has called for phasing out the nontherapeutic use of antimicrobials in farm animals in order to maintain the effectiveness of antibiotics in humans.

Apr 03, 2008

Apr 03, 2008

China approves its first H5N1 vaccine

(CIDRAP News) – China's State Food and Drug Administration (SFDA) yesterday approved the country's first prepandemic H5N1 influenza vaccine, an inactivated whole-virus product made by Sinovac, a Beijing-based biotechnology company.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»